Screener
Viridian Therapeutics, Inc. VRDN Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from Viridian Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Viridian Therapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:31 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001590750-26-000018
FAQ
- What is Viridian Therapeutics, Inc.'s price / sales?
- Viridian Therapeutics, Inc. (VRDN) reported price / sales of 28.5× in Q2 2026.
- How has Viridian Therapeutics, Inc.'s price / sales changed year-over-year?
- Viridian Therapeutics, Inc.'s price / sales decreased by 99.3% year-over-year, from 3,921.8× to 28.5×.
- What is the long-term trend for Viridian Therapeutics, Inc.'s price / sales?
- Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s price / sales has grown at a -15.8% compound annual growth rate (CAGR), from 99.3× to 41.9×.
- What does price / sales mean?
- Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.
Ask your AI about Viridian Therapeutics, Inc.'s price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude